Related Experiment Video
Updated: May 30, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
Published on: May 17, 2024
Diagnosis and management of patients with white-coat and masked hypertension
Giuseppe Mancia1, Michele Bombelli, Gino Seravalle
1Clinica Medica, Dipartimento di Medicina Clinica, Prevenzione e Biotecnologie Sanitarie, Università Milano-Bicocca, Ospedale San Gerardo, Via Pergolesi 33, 20052 Monza, Italy. giuseppe.mancia@ unimib.it
Insights
White-coat hypertension (high clinic blood pressure) and masked hypertension (normal clinic blood pressure) require careful diagnosis. Both conditions are linked to increased cardiovascular and metabolic risks, necessitating lifestyle changes or medication.
Area of Science:
- Cardiology
- Hypertension Management
Background:
- White-coat hypertension (WCH) involves elevated clinic blood pressure with normal out-of-office readings.
- Masked hypertension (MH) presents with normal clinic blood pressure but elevated out-of-office readings.
- Both WCH and MH are common and require accurate diagnosis and monitoring.
Purpose of the Study:
- To highlight the clinical significance of WCH and MH.
- To emphasize the association of WCH and MH with cardiovascular and metabolic risks.
- To guide diagnostic and therapeutic approaches for WCH and MH.
Main Methods:
- The study reviews the definitions and clinical implications of WCH and MH.
- It discusses the diagnostic evaluation, including ambulatory blood pressure monitoring.
- It outlines therapeutic strategies based on risk assessment.
Main Results:
- WCH and MH are associated with increased cardiovascular risk and organ damage, though not always.
- Patients with WCH or MH have a higher risk of glucose and lipid profile abnormalities.
- Accurate diagnosis is crucial for assessing overall cardiovascular and metabolic risk.
Conclusions:
- Diagnosis of WCH and MH necessitates comprehensive cardiovascular and metabolic risk assessment.
- First-line treatment involves non-pharmacological lifestyle modifications.
- Pharmacological treatment is considered for elevated cardiovascular risk or target-organ damage.
Abstract:
White-coat hypertension is characterized by an elevation in clinic blood pressure but normal home or ambulatory blood-pressure values, whereas patients with masked hypertension have normal clinic blood pressure and elevated ambulatory or home blood-pressure load. Both white-coat and masked hypertension are frequent clinical entities that need appropriate recognition and a close diagnostic follow-up. White-coat and masked hypertension seem to be associated with organ damage and increased cardiovascular risk, although not invariably. In addition, patients with masked or white-coat hypertension have an increased risk of abnormalities affecting their glucose and lipid profiles. Therefore, the diagnosis of these conditions should be accurate and include the assessment of cardiovascular as well as of metabolic risk. Once diagnosed, first-line therapeutic interventions should be nonpharmacological and aim at lifestyle changes, but drug treatment can be indicated, particularly when the patient's cardiovascular risk profile is elevated or when target-organ damage is detected.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension V: Nursing Management
Hypertension I: Introduction
Hypertension and Regulation of Blood Pressure
Hypertension IV: Drug Therapy and Lifestyle Modifications
Errors occurring during blood pressure monitoring
Several factors...